Citation Impact
Citing Papers
Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol
2012
The prognostic significance of bacterial DNA in patients with decompensated cirrhosis and suspected infection
2016
Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers
2016
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2015
Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis
2016
Nonselective β‐blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients
2015
Emerging therapies for the treatment of hepatitis C
2013 StandoutNobel
Prevalence of sero-markers and non-invasive assessment of liver cirrhosis in patients with Hepatitis B virus infection in Freetown, Sierra Leone: a cross-sectional study
2021
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma
2014
Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics
2010
Cardiac dysfunction in patients with cirrhosis
2015
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Beta adrenergic blockade and decompensated cirrhosis
2016
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Acute-on-chronic liver failure: A distinct clinical syndrome
2021
Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites
2016
Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis
2014
Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis
2010
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Burden of liver diseases in the world
2018 Standout
Liver cirrhosis
2014
Pathogenesis of Hepatorenal Syndrome: Implications for Therapy
2015
Inflammation and portal hypertension – The undiscovered country
2014
Oral Anticoagulant Therapy
2012 Standout
Spontaneous bacterial peritonitis: recent guidelines and beyond
2011
Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
2013
Hepatocellular carcinoma
2012 Standout
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
2010 Standout
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Pulmonary contraindications, indications and MELD exceptions for liver transplantation: A contemporary view and look forward
2013
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging
2015
β‐Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta‐analysis
2009
Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography
2014
Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy
2015
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Acute kidney injury
2019 Standout
Portal hypertensive bleeding in cirrhosis
2016 Standout
Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
2009
Evaluation of Early-Stage Hepatocellular Carcinoma by Magnetic Resonance Imaging With Gadoxetic Acid Detects Additional Lesions and Increases Overall Survival
2015
Cirrhotic cardiomyopathy: pathogenesis and clinical relevance
2013
Non-alcoholic fatty liver disease and liver transplantation
2016
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Liver Imaging Reporting and Data System: Discordance Between Computed Tomography and Gadoxetate-Enhanced Magnetic Resonance Imaging for Detection of Hepatocellular Carcinoma Major Features
2017
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Global burden of liver disease: 2023 update
2023 Standout
Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding
2014
Epidemiology, Pathophysiology, and Management of Hepatorenal Syndrome
2018
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Increased size of solid organs in patients with Chuvash polycythemia and in mice with altered expression of HIF-1α and HIF-2α
2010 StandoutNobel
Hepatic hydrothorax: An update and review of the literature
2017
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis
2012
Idiopathic pulmonary fibrosis
2011 Standout
Serum bilirubin and platelet count: A simple predictive model for survival in patients with refractory ascites treated by TIPS
2010
Thoracoscopic Mesh Repair of Diaphragmatic Defects in Hepatic Hydrothorax: A 10-Year Experience
2016
Non-selective β-blockers are associated with improved survival in patients with ascites listed for liver transplantation
2014
MicroRNA group disorganization in aging
2009
Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis
2013
Hepatocellular Carcinoma
2011 Standout
Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs
2019
Hepatocellular Carcinoma: Diagnostic Performance of Multidetector CT and MR Imaging—A Systematic Review and Meta-Analysis
2015
Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays
2010 StandoutNobel
Increased Fructose Consumption Is Associated With Fibrosis Severity in Patients With Nonalcoholic Fatty Liver Disease
2010
Evidence Supporting LI-RADS Major Features for CT- and MR Imaging–based Diagnosis of Hepatocellular Carcinoma: A Systematic Review
2017
Imaging Outcomes of Liver Imaging Reporting and Data System Version 2014 Category 2, 3, and 4 Observations Detected at CT and MR Imaging
2016
Hepatocellular carcinoma
2022 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Hepatocellular Carcinoma
2019 Standout
Severe Alcohol‐Associated Hepatitis Is Associated With Worse Survival in Critically Ill Patients With Acute on Chronic Liver Failure
2021
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Population pharmacokinetics and pharmacodynamics of once and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement
2008
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
2018
LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directions
2014
Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure
2015
2017
Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting
2019
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease: Figure 1
2012
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight
2016
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis
2017
Dynamic enhancement pattern of HCC smaller than 3 cm in diameter on gadoxetic acid‐enhanced MRI : comparison with multiphasic MDCT
2014
Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications
2012
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma
2015
Works of Thomas Sersté being referenced
The use of beta‐blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis
2015
Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: A cross-over study
2011
The impact of preoperative hepatic hydrothorax on the outcome of adult liver transplantation
2010
Detection of bacterial DNA in serum and ascitic fluid of asymptomatic outpatients with cirrhosis and non-neutrocytic ascites
2011
Metabolic disorders associated with chronic hepatitis C: impact of genotype and ethnicity
2010
Deleterious Effects of Beta-Blockers on Survival in Patients With Cirrhosis and Refractory Ascites†,‡
2010
Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites
2012
Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients
2017
The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis
2018
855 DELETERIOUS EFFECTS OF BETA-BLOCKERS ON SURVIVAL AND PARACENTESIS INDUCED CIRCULATORY DYSFUNCTION IN PATIENTS WITH CIRRHOSIS AND REFRACTORY ASCITES
2010
Relationship between the degree of portal hypertension and the onset of spontaneous bacterial peritonitis in patients with cirrhosis.
2007
Ageing and the liver.
2007
Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: Role of biopsy
2011